Stock GUD KNIGHT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Knight Therapeutics Inc.

Equities

GUD

CA4990531069

Market Closed - Toronto S.E.
Other stock markets
 16:00:00 2024-05-03 EDT 		5-day change 1st Jan Change
5.91 CAD +1.55% Intraday chart for Knight Therapeutics Inc. +3.14% +13.87%
03-22 Knight Therapeutics Price Target Raised to $7 at RBC MT
03-21 Knight Therapeutics Reports Fourth Quarter Results MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Knight Therapeutics Price Target Raised to $7 at RBC
MT
National Bank Downgrades Knight Therapeutics to Sector Perform, Cuts Price Target to $6, on "Soft" Outlook
MT
Knight Therapeutics Hold Rating Maintained by Stifel GMP as Q2 Results Beat Forecasts; Price Target Raised to C$5.40
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GUD Stock
  4. News Knight Therapeutics Inc.
  5. Analyst Reco.